Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TP53 and head and neck neoplasms.

Hélène Blons1, Pierre Laurent-Puig

  • 1U490 INSERM Laboratoire de Toxicologie Moléculaire, Paris, France.

Human Mutation
|March 6, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Profiling of Urothelial Bladder Cancer: Bridging Tumor Biology and Clinical Decision-making.

European urology oncology·2026
Same author

Integrative and interactive genomic analyses guiding personalized combined therapy improve clinical benefit in metastatic patients: A monocentric real-life experience.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Blood and Urine Circulating Tumor DNA in Urothelial Bladder Cancer: State of the Art and Clinical Perspective.

European urology oncology·2026
Same author

Circulating Tumor DNA Dynamics and Clinical Outcomes in Patients with Advanced Colorectal Cancer Treated with Cetuximab-Based Induction and Maintenance Treatment.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis.

The Lancet regional health. Europe·2025
Same author

Characteristics of <i>KRAS</i> WT pancreatic adenocarcinomas: results of a large French multicentric cohort.

Therapeutic advances in medical oncology·2025

Head and neck squamous cell carcinoma (HNSCC) involves p53 pathway disruptions from tobacco, alcohol, and HPV. Understanding TP53 alterations may guide HNSCC prognosis and treatment response.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Head and neck squamous cell carcinoma (HNSCC) is a significant global health issue, with ~500,000 new cases annually.
  • Carcinogenesis in head and neck cancers involves dysregulated cellular processes: proliferation, differentiation, and cell death.
  • Key etiologic factors including tobacco, alcohol, and human papillomavirus (HPV) converge on disrupting the critical p53 pathway.

Purpose of the Study:

  • To review the specific alterations of the p53 gene (TP53) in head and neck cancer.
  • To examine the relationship between TP53 alterations and chemocarcinogenesis.
  • To evaluate the clinical relevance of determining p53 alterations for HNSCC prognosis and treatment response.

Main Methods:

  • Literature review focusing on TP53 gene alterations in HNSCC.

Related Experiment Videos

  • Analysis of the role of p53 pathway in head and neck carcinogenesis.
  • Discussion of clinical implications of p53 status in HNSCC management.

    • Main Results:

    • The p53 pathway is frequently disrupted in HNSCC by major risk factors.
    • Specific TP53 alterations characterize head and neck carcinogenesis.
    • Evidence suggests TP53 status may correlate with prognosis and treatment outcomes.

    Conclusions:

    • TP53 alterations are specific to head and neck cancer development.
    • Assessing p53 status holds potential clinical relevance for personalized HNSCC management.
    • Further research is warranted to fully elucidate the prognostic and predictive value of TP53 alterations.